Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters









Publication year range
1.
Characterization of South-East Asian ovalocytosis using osmotic gradient ektacytometry / Caracterización de la ovalocitosis del sud-este asiático mediante ectacitometría de gradiente osmótico
Canelo-Vilaseca, Marta; Hernández-Rodríguez, Inés; Navarro, José-Tomás.
Med. clín (Ed. impr.) ; 162(1): 43-43, ene. 2024. ilus
Article in English | IBECS | ID: ibc-229049

Subject(s)
Humans , Female , Young Adult , Elliptocytosis, Hereditary/diagnosis , Elliptocytosis, Hereditary/genetics
2.
Characterization of South-East Asian ovalocytosis using osmotic gradient ektacytometry.
Canelo-Vilaseca, Marta; Hernández-Rodríguez, Inés; Navarro, José-Tomás.
Med Clin (Barc) ; 162(1): 43, 2024 01 12.
Article in English, Spanish | MEDLINE | ID: mdl-37573169

Subject(s)
Elliptocytosis, Hereditary , Hematologic Diseases , Humans , East Asian People , Elliptocytosis, Hereditary/diagnosis , Elliptocytosis, Hereditary/genetics , Erythrocytes
3.
HHV8 and EBV-negative primary effusion-based lymphoma: A case report of a new provisional entity and review of literature.
Canelo-Vilaseca, Marta; Tapia, Gustavo; Orna, Elisa; Sorigué, Marc; Granada, Isabel; Palomar-Muñoz, Azahara; Castillo, Ana; Grau, Javier; Mesa, Alba; Ribera, Josep-Maria; Sancho, Juan-Manuel; Navarro, José-Tomás.
Clin Case Rep ; 11(5): e7282, 2023 May.
Article in English | MEDLINE | ID: mdl-37180332

ABSTRACT

Key Clinical Message: HHV8- and EBV-negative primary effusion lymphoma is an extremely rare neoplasm involving body cavities without detectable tumor mass. It usually presents in elderly patients without known immunodeficiency. Compared to primary effusion lymphoma, it has a better prognosis.Primary effusion lymphoma (PEL) is a rare non-Hodgkin lymphoma confined exclusively to body cavities without detectable tumor masses. The term PEL-like is an entity similar to PEL in clinical presentation but without relation to human herpesvirus 8 (HHV8). We report a case of HHV8- and EBV-negative primary effusion-based lymphoma.

4.
Sobrecarga férrica refractaria a flebotomías en un paciente con hemocromatosis hereditaria tipo 1 / Iron overload refractory to phlebotomy in a patient with type 1 hereditary hemochromatosis
Canelo-Vilaseca, Marta; Ribera, Josep-Maria; Hernández-Rodríguez, Inés.
Med. clín (Ed. impr.) ; 160(8): 372-372, abril 2023. ilus
Article in Spanish | IBECS | ID: ibc-219103

Subject(s)
Humans , Male , Middle Aged , Hemochromatosis/complications , Hemochromatosis/diagnosis , Hemochromatosis/genetics , Iron Overload/etiology , Phlebotomy
5.
[Iron overload refractory to phlebotomy in a patient with type 1 hereditary hemochromatosis]. / Sobrecarga férrica refractaria a flebotomías en un paciente con hemocromatosis hereditaria tipo 1.
Canelo-Vilaseca, Marta; Ribera, Josep-Maria; Hernández-Rodríguez, Inés.
Med Clin (Barc) ; 160(8): 372, 2023 04 21.
Article in English, Spanish | MEDLINE | ID: mdl-36529556

Subject(s)
Hemochromatosis , Iron Overload , Humans , Hemochromatosis/complications , Hemochromatosis/diagnosis , Hemochromatosis/genetics , Phlebotomy , Iron Overload/etiology
6.
Colitis por idelalisib en un paciente con linfoma folicular / Colitis due to idelalisib in a patient with follicular lymphoma
Canelo-Vilaseca, Marta; Ribera Santasusana, Josep-Maria; Sancho Cia, Juan-Manuel.
Med. clín (Ed. impr.) ; 159(2): 106-106, julio 2022. ilus
Article in Spanish | IBECS | ID: ibc-206313

Subject(s)
Humans , Antineoplastic Agents/adverse effects , Colitis , Leukemia, Lymphocytic, Chronic, B-Cell/therapy , Lymphoma, Follicular/complications , Lymphoma, Follicular/therapy , Purines/adverse effects , Quinazolinones/adverse effects
7.
Colitis due to idelalisib in a patient with follicular lymphoma. / Colitis por idelalisib en un paciente con linfoma folicular.
Canelo-Vilaseca, Marta; Ribera Santasusana, Josep-Maria; Sancho Cia, Juan-Manuel.
Med Clin (Barc) ; 159(2): 106, 2022 07 22.
Article in English, Spanish | MEDLINE | ID: mdl-35525678

Subject(s)
Antineoplastic Agents , Colitis , Leukemia, Lymphocytic, Chronic, B-Cell , Lymphoma, Follicular , Antineoplastic Agents/adverse effects , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Lymphoma, Follicular/complications , Lymphoma, Follicular/drug therapy , Purines/adverse effects , Quinazolinones/adverse effects
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL